Cargando…
Successful management of severe bronchial asthma exacerbated by anti‐PD‐L1 treatment: A report of two cases
Immune checkpoint inhibitors (ICIs) have been used for various carcinomas. However, immune‐related adverse events have been observed. There have been few reports of treatment with biologics for severe bronchial asthma induced by ICI; therefore, their efficacy is unknown. We report two cases of sever...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Ltd
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542805/ https://www.ncbi.nlm.nih.gov/pubmed/34721879 http://dx.doi.org/10.1002/rcr2.868 |